Jay S. Markowitz, M.D. has spent 19 years analyzing, investing, and working in the biopharmaceutical industry. He is currently a Senior Partner at ARCH, joining the firm in 2021. In 2020 he was a Vice President and Sector Portfolio Manager at T. Rowe Price; from 2017-2020 he was a Senior Vice President at Regeneron Pharmaceuticals; from 2010-2017 he was the U.S. pharmaceutical and biotechnology analyst at Capital World Investors; and from 2002-2010 he was a biotechnology analyst with investment responsibility at T. Rowe Price. Before transitioning to an investment career, he was an assistant professor and transplant surgeon at the Johns Hopkins University School of Medicine (1999-2002) and the University of Medicine and Dentistry of New Jersey (1997-1999).
Dr. Markowitz received his B.A. from Columbia University and his M.D. from Duke University. He completed a fellowship in transplant surgery at the UCLA Medical Center, a surgical residency at Massachusetts General Hospital, and a Research Fellowship in Cellular and Molecular Immunology at the Harvard School of Public Health.